Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Opinion Fellow Talk

How to Build and Sustain a Referral Base: Lessons From Observing My Mentors

Rahul Sharma, MD

December 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News AHA 2016

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Yael L. Maxwell

November 21, 2016

News Daily News

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Yael L. Maxwell

November 10, 2016

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

Presentation TCT 2016

Editorial Comment: Current Techniques, Device Selection, and Outcomes

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Thomas D. Stuckey

November 01, 2016

Presentation TCT 2016

Physician and Management Partnerships: Benefits and Challenges

Presenter: Robert J. Applegate, Charles E. Chambers, Megan Berlinger

October 29, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

Todd Neale

August 27, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

Advertisement

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

How to Build and Sustain a Referral Base: Lessons From Observing My Mentors

TCTMD’s Top 10 Most Popular Stories for November 2016

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Editorial Comment: Current Techniques, Device Selection, and Outcomes

Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies

Physician and Management Partnerships: Benefits and Challenges

TCTMD’s Top 10 Most Popular Stories for September 2016

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

New ESC A-fib Guidelines Call for Integrated Care for All Patients

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Decline Seen in Readmissions After PCI in the Medicare Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content